ZDZT
Zhengduozhe Technology Inc., operating as DAKOTA Life Sciences, is a biopharmaceutical enterprise dedicated to the acquisition, development, and commercialization of therapeutic agents. These pharmaceuticals are specifically engineered to prevent and treat severe medical conditions encountered in both clinical and community environments. A central focus for the company involves delivering solutions to individuals grappling with antimicrobial resistance and ensuring that necessary medications are available at reasonable prices. The firm was established in 1986 and is headquartered in Sioux Falls, South Dakota.
| Period | EPS | Revenue | FCF |
|---|---|---|---|
| 2024 Q4 | -0.00 | $250,610 | — |
| 2024 Q3 | 0.00 | $36,224 | — |
| 2024 Q2 | 0.00 | $2,819 | -$568,466 |
| 2024 Q1 | -0.00 | $16,536 | -$21,404 |
| 2023 Q4 | 0.00 | $160,239 | $35,210 |
| 2023 Q3 | 0.00 | $42,364 | $513,401 |
| 2023 Q2 | -0.00 | $27,437 | -$9,932 |
| 2023 Q1 | -0.00 | $0 | -$5,389 |